NCT01903005 - Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence | Biotech Hunter

Enrollment

668

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Opioid Dependence, on Agonist Therapy

Interventions

DRUG

Higher bioavailability BNX sublingual tablets

Once daily, open-label treatment with higher bioavailability BNX sublingual tablets for 24 weeks

Trial Locations (28)

Jefferson County

Marion County

Winston County

Maricopa County

Los Angeles County

San Diego County

Broward County

Columbia County

Duval County

Jacksonville Metropolitan Area

Miami-Dade County

Orlando Metropolitan Area

Osceola County

Palm Beach County

DeKalb County

Chicago Metropolitan Area

Baltimore County

Bristol County

Rankin County

Saint Louis Metropolitan Area

Warren County

Oklahoma County

Portland Metropolitan Area

Delaware County

Philadelphia County

Charleston County

Salt Lake County

Benton County